Insider buying
~$80K10K sh @ $7.98
Traded Oct 23, 2024 · filed 2 days later
A major shareholder of Eton Pharmaceuticals paid $80K out of pocket for Eton Pharmaceuticals shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 7, 2024 · Filed Oct 8, 2024
A major shareholder of Eton Pharmaceuticals paid $72K out of pocket for Eton Pharmaceuticals shares.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$72,235
Shares × reported transaction price
$25K–$100K
+0.4%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
60 days after results of Aug 8, 2024, 36 days before results of Nov 12, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +6.9% | +0.9% | +6.0% |
| 30 days | +13.7% | +3.6% | +10.1% |
| 90 days | +55.3% | +2.0% | +53.3% |
| 180 days | +53.5% | −12.6% | +66.1% |
| 365 days | +162.7% | +16.3% | +146.4% |
Past results only. Not a forecast.
Insider buying
Traded Oct 23, 2024 · filed 2 days later
A major shareholder of Eton Pharmaceuticals paid $80K out of pocket for Eton Pharmaceuticals shares.
Insider buying
Traded Oct 8, 2024 · filed the same day
A major shareholder of Eton Pharmaceuticals paid $28K out of pocket for Eton Pharmaceuticals shares. Shares held went up 5% with this purchase.
Insider buying
Traded Oct 4, 2024 · filed 4 days later
A major shareholder of Eton Pharmaceuticals paid $13K out of pocket for Eton Pharmaceuticals shares. It was the first purchase in over a year.
Opaleye Management Inc., 10% owner's past purchases, 90 days after disclosure: 64 buys, median +3.2 pts vs S&P 500, beat it 36 of 64 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.